Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study - Milan 2017

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

New insights into pulmonary hypertension from recent trials

Chair(s): L. Rubin (New York, United States of America), O. Sitbon (Le Kremlin-Bicêtre, France)

Session type: Oral Presentation

Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study

G. Simonneau (Le Kremlin-Bicêtre, France)

EVENTS HOME

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

The ERS International Congress 2017, Milan